Merck, the German pharmaceuticals company that last week bid Sfr16.6bn (€11bn) for Swiss biotech firm Serono, has appointed three banks to finance its offer.
Bear Stearns, Dresdner Kleinwort and SG Corporate and Investment Banking are arranging an €11.5bn ($15bn) loan to fund the acquisition.